Atlas Trials

A Study to Assess the Safety and Efficacy of IC265 Ophthalmic Solution for Dry Eye in Adult Participants

Clinical trial NCT05992922 · TERMINATED

Trial details

NCT number
NCT05992922
Sponsor
Iacta Pharmaceuticals
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Dry Eye Syndromes
Start date
2023-10-17
Primary completion
2023-12-19
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.